HCPCS code J2350 — Injection, ocrelizumab, 1 mg.
Status: Active.
Effective Jan 1, 2018.
Source: CMS HCPCS Level II.
J2350
ActiveInjection, ocrelizumab, 1 mg
Category:
Drugs
Section:
J-codes: Drugs Administered Other Than Oral Method
Effective:
Jan 1, 2018
Code type:
alphanumeric
OPPS Status:
K
— Non-pass-through drugs and biologicals
OPPS APC:
9494
Drug class:
Anti-CD20 Monoclonal Antibodies
MUE — Medically Unlikely Edits
Maximum units of J2350 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.
| Service Type | Max Units / Day |
|---|---|
| DME Supplier | 0 |
| Outpatient Hospital | 600 |
| Practitioner Services | 600 |
Source: CMS Medicare NCCI Medically Unlikely Edits
NDC Crosswalk
National Drug Codes (NDCs) mapped to this HCPCS code.
| NDC | Drug Name |
|---|---|
| 50242-0150-01 | Ocrevus |